AI Evaluation Notes

The 'China plus one' strategy involves companies diversifying their supply chains to reduce reliance on China. Pharmaceutical companies have indeed been expanding manufacturing and supply chains outside of China, indicating the prediction is somewhat accurate, though it's difficult to definitively quantify the extent to which the pharmaceutical industry has been the 'primary beneficiary'.